RevealDx
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Healthcare, Artificial Intelligence, Medical Software
- Founded
- 2022 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Precision Medical Ventures Inc Seattle business license
- Stage
- Seed
- Founders
- Michael Calhoun, PhD
RevealDx Secures Distribution Deal and $3.4M Investment from 4DMedical to Expand Chest CT AI Globally
RevealDx signed a distribution agreement and received a $3.4 million investment from 4DMedical to distribute its chest CT AI software across the U.S., Europe, Australia and New Zealand.
GeekWire 2026 Innovation of the Year Finalists Include Alpenglow Biosciences and Pacific Northwest National Laboratory
The 2026 GeekWire Awards announced finalists for Innovation of the Year, including Alpenglow Biosciences, Pacific Northwest National Laboratory, RevealDx, Starcloud, and VerAvanti, recognized for breakthroughs in healthcare and data center technology. The awards event will be held on May 7 in Seattle, with public voting open through April 10.
Seattle Startup RevealDx Raises $4.25M to Improve Lung Cancer Diagnosis with AI Technology
Seattle startup RevealDx raised $4.25 million to enhance lung cancer diagnosis using machine learning to analyze chest CT scans, aiming to accelerate diagnosis and reduce false positives. The company, formerly Mindshare Medical, is expanding in Europe and pursuing FDA approval in the U.S.
